scholarly journals Non-invasive ventilation through a nasal interface during transoesophageal echocardiogram in a high-risk chronic patient

Pulmonology ◽  
2021 ◽  
Author(s):  
R.E. Gomes ◽  
M.T. Redondo ◽  
M.R. Gonçalves
Keyword(s):  
High Risk ◽  
Invasive Ventilation ◽  
Chronic Patient ◽  
Non Invasive ◽  
Non Invasive Ventilation

scholarly journals Non-invasive ventilation-aided transoesophageal echocardiography in high-risk patients: a pilot study

2010 ◽  
Vol 11 (6) ◽  
pp. 554-556 ◽  
Author(s):  
F. Guarracino ◽  
L. Cabrini ◽  
R. Baldassarri ◽  
C. Cariello ◽  
R. D. Covello ◽  
...  
Keyword(s):  
Pilot Study ◽  
High Risk ◽  
Transoesophageal Echocardiography ◽  
Invasive Ventilation ◽  
High Risk Patients ◽  
Non Invasive ◽  
Non Invasive Ventilation ◽  
Risk Patients

scholarly journals Risk of COVID-19 Infection in Healthcare Workers Exposed During Use of Non-invasive Ventilation in a Tertiary Care Hospital in OmanRisk of COVID-19 Infection in Healthcare Workers Exposed During Use of Non-invasive Ventilation in a Tertiary Care Hospital in Oman

2021 ◽  
Vol 36 (2) ◽  
pp. e236-e236
Author(s):  
Adil Al Lawati ◽  
Faryal Khamis ◽  
Samiha Al Habsi ◽  
Khazina Al Dalhami
Keyword(s):  
High Risk ◽  
Healthcare Workers ◽  
Tertiary Care Hospital ◽  
Tertiary Care ◽  
Significant Risk ◽  
High Risk Population ◽  
Care Hospital ◽  
Invasive Ventilation ◽  
Non Invasive ◽  
Non Invasive Ventilation

Objectives: Healthcare workers (HCWs), especially those working on the front line, are considered to be at high risk of nosocomial acquisition of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). Little is known about the effectiveness of the recommended protective methods as few reports have described spread of the disease in hospital settings among this high-risk population. We describe the hospital-based transmission of SARS-CoV-2 related to non-invasive ventilation (NIV) in one of the main tertiary care hospitals in Oman. Methods: All exposed patients and HCWs from Royal Hospital were screened, quarantined, and underwent telephone interviews to stratify their risk factors, clinical symptoms, and exposure risk assessment. Results: A total of 46 HCWs and patients tested positive for SARS-CoV-2 after exposure to an index case who received 48 hours of NIV before diagnosing COVID-19 infection. Over half of the exposed (56.5%; n = 26) were nurses, 26.1% (n = 12) were patients, and 15.2% (n = 7) were doctors. None of the HCWs required hospitalization. Sore throat, fever, and myalgia were the most common symptoms. Conclusions: NIV poses a significant risk for SARS-CoV-2 transmission within hospital settings if appropriate infection control measures are not taken.

scholarly journals High-flow nasal cannula oxygen therapy alone or with non-invasive ventilation during the weaning period after extubation in ICU: the prospective randomised controlled HIGH-WEAN protocol

BMJ Open ◽  
2018 ◽  
Vol 8 (9) ◽  
pp. e023772 ◽  
Author(s):  
Arnaud W Thille ◽  
Grégoire Muller ◽  
Arnaud Gacouin ◽  
Rémi Coudroy ◽  
Alexandre Demoule ◽  
...  
Keyword(s):  
Respiratory Failure ◽  
High Risk ◽  
Oxygen Therapy ◽  
Extubation Failure ◽  
High Flow ◽  
Invasive Ventilation ◽  
High Flow Nasal Cannula ◽  
Non Invasive ◽  
Non Invasive Ventilation ◽  
Randomised Controlled

IntroductionRecent practice guidelines suggest applying non-invasive ventilation (NIV) to prevent postextubation respiratory failure in patients at high risk of extubation failure in intensive care unit (ICU). However, such prophylactic NIV has been only a conditional recommendation given the low certainty of evidence. Likewise, high-flow nasal cannula (HFNC) oxygen therapy has been shown to reduce reintubation rates as compared with standard oxygen and to be as efficient as NIV in patients at high risk. Whereas HFNC may be considered as an optimal therapy during the postextubation period, HFNC associated with NIV could be an additional means of preventing postextubation respiratory failure. We are hypothesising that treatment associating NIV with HFNC between NIV sessions may be more effective than HFNC alone and may reduce the reintubation rate in patients at high risk.Methods and analysisThis study is an investigator-initiated, multicentre randomised controlled trial comparing HFNC alone or with NIV sessions during the postextubation period in patients at high risk of extubation failure in the ICU. Six hundred patients will be randomised with a 1:1 ratio in two groups according to the strategy of oxygenation after extubation. The primary outcome is the reintubation rate within the 7 days following planned extubation. Secondary outcomes include the number of patients who meet the criteria for moderate/severe respiratory failure, ICU length of stay and mortality up to day 90.Ethics and disseminationThe study has been approved by the ethics committee and patients will be included after informed consent. The results will be submitted for publication in peer-reviewed journals.Trial registration numberNCT03121482.

Sign in / Sign up

Export Citation Format

Share Document